| Following Our Recent Biotech Profile That Moved Approximately 144% In Just 4 Sessions, It's Time To Reveal What We've Just Discovered As Concerns Rise About A Severe Strain Of M-pox Spreading!
Get ready for our brand new profile announcement coming tonight at 8:00 PM EST or tomorrow morning at 9:30 AM EST!
This Next BioPharma Comes Stacked with Several Potential Catalysts Including:
Innovative Antiviral Technology: Developing a Direct-Acting Antiviral Dr-ug That Disables Viruses Before They Can Infect Human Cells!
Small Float: Less Than 12M Shares Available, Creating Potential For Significant Price Movement!
Untapped Potential: Market Cap Under $30M Suggests Wall Street May Have Overlooked This, Offering Strong Growth Potential!
Bullish Indicators: Perfect Score On Barchart With 13/13 Bullish Indicators And 16 Bullish Signals On TradingView!
Innovative Antiviral Technology: Developing NV-387, A Direct-Acting Antiviral Drug That Disables Viruses Before They Can Infect Human Cells!
Don’t Miss Out on This One!
Take 2 Minutes Now to Connect with Us on all of Our No-Cost Platforms!
(See instructions below)
August 18, 2024
Dear Reader,
Following our recent biotech profile, which we introduced on Wednesday night (8/7), and opened at $1.03 the next morning (8/8) before reaching $2.52 by Tuesday (8/12), resulting in an approximate 144% gain over four sessions, we now need to shift our focus to an urgent situation.
Get ready for our brand new profile announcement coming tonight at 8:00 PM EST or tomorrow morning at 9:30 AM EST!
As concerns rise about a severe strain of m-pox spreading in Africa, experts are cautiously optimistic that this variant won't have a significant impact in the U.S., thanks to factors like vax immunity, previous infections, and better healthcare.
However, the World Health Organization has reinstated m-pox as a public health emergency due to a large outbreak of clade I in the Democratic Republic of Congo, which has spread to other African nations.
In light of these developments, we have identified one little-known company that could be strategically positioned to address this growing concern.
This is a company that needs to be on your watchlist right now, as its potential to impact this critical area could be significant.
Get ready for our brand new profile announcement coming tonight at 8:00 PM EST or tomorrow morning at 9:30 AM EST!
This next profile is backed by several potential catalysts including:
- Small Float: Less than 12M shares available, creating potential for significant price movement.
- Untapped Potential: Market cap under $30M suggests Wall Street may have overlooked this, offering strong growth prospects.
- Bullish Indicators: Perfect score on Barchart with 13/13 bullish indicators and 16 bullish signals on TradingView.
- Innovative Antiviral Technology: Developing NV-387, a direct-acting antiviral dr-ug that disables viruses before they infect human cells.
- Broad-Spectrum Effectiveness: Demonstrated efficacy against a wide range of viruses.
- Significant Market Potential: Targeting a market expected to grow to $12B in the next three years.
- Addressing Viral Resistance: Designed to prevent rapid viral resistance, a major challenge in current antiviral treatments.
- Advanced Clinical Trials: Actively progressing through Phase I and preparing for Phase II to evaluate its effectiveness.
Now, it’s time to get ready for our brand new profile.
It’s coming tonight at 8:00 PM EST or tomorrow morning at 9:30 AM EST.
In the meantime, I’m urging you to connect with us on all of our no-cost platforms so you can receive our reports up to 10X faster than email alone.
If you haven’t done so yet, please take 2 minutes to set these up right now, so you don’t miss out on future profiles:
1. Confirm your mobile device is already connected to our no-cost SMS by clicking here.
2. Join our no-cost Telegram Channel by clicking here.
3. Connect with us on WhatsApp by clicking here.
All three of these should take less than 3 minutes to connect but could give you a massive advantage in the market.
I’ll check back tonight or early tomorrow morning – so get ready now. | 
No comments:
Post a Comment